We are live on ! Find out more
AC

Ayrton Capital Portfolio holdings

AUM $14.7M
1-Year Est. Return 12.82%
This Fund
S&P 500
This Quarter Est. Return
-6.73%
1 Year Est. Return
-12.82%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$16M
AUM Growth
-$11.8M
Cap. Flow
-$21.9M
Cap. Flow %
-136.91%
Top 10 Hldgs %
86.36%
Holding
93
New
6
Increased
1
Reduced
3
Closed
19
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BTM
1
DELISTED
Bitcoin Depot
BTM
$1.05M 6.54%
14,286
PMCB icon
2
PharmaCyte Biotech
PMCB
$6.44M
$792K 4.95%
276,992
-753,538
-73% -$2.26M
OTEC
3
DELISTED
OceanTech Acquisitions I Corp. Class A Common Stock
OTEC
$760K 4.74%
70,000
-55,000
-44% -$595K
SHFS icon
4
SHF Holdings
SHFS
$1.25M
$624K 3.9%
58,912
EUDA icon
5
EUDA Health Holdings
EUDA
$44.9M
$359K 2.24%
23,647
-24,244
-51% -$667K
SHPH icon
6
Shuttle Pharmaceuticals
SHPH
$1.69M
$289K 1.8%
+125
New +$308K
ATXG icon
7
Addentax Group
ATXG
$3.82M
$217K 1.35%
+2,202
New +$266K
RCON icon
8
Recon Technology
RCON
$42.7M
$196K 1.22%
31,586
PAVM icon
9
PAVmed
PAVM
$33.9M
$183K 1.14%
999
+43
+4% +$8.6K
PEPL
10
DELISTED
PepperLime Health Acquisition Corporation Class A Ordinary Share
PEPL
$136K 0.85%
13,028
POL.WS
11
DELISTED
Polished.com Inc. Warrants to Purchase Common Stock
POL.WS
$130K 0.81%
2,000,000
AUUD
12
Auddia
AUUD
$5.74M
$99.4K 0.62%
+74
New +$121K
KSCP icon
13
Knightscope
KSCP
$25M
$67.9K 0.42%
+2,558
New +$67.7K
SKYAW
14
SkyAI Inc
SKYAW
$290K
$33.2K 0.21%
235,200
ACAXR
15
DELISTED
Alset Capital Acquisition Corp Right
ACAXR
$31.6K 0.2%
100,000
ZIVOW
16
DELISTED
Zivo Bioscience, Inc. Warrants
ZIVOW
$29.3K 0.18%
48,850
LUCYW icon
17
Innovative Eyewear Inc Series A Warrants 8/16/27
LUCYW
$95K
$28.7K 0.18%
150,900
WKSPW
18
DELISTED
Worksport, Ltd. Warrant
WKSPW
$20.2K 0.13%
86,020
BEATW icon
19
Heartbeam Inc Warrant
BEATW
$68.5K
$20K 0.12%
50,000
ONFOW icon
20
Onfolio Holdings Warrant
ONFOW
$20K 0.12%
100,000
AAC.WS
21
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$19.9K 0.12%
24,851
NLSPW
22
DELISTED
NLS Pharmaceutics Warrant
NLSPW
$18.2K 0.11%
170,100
SOC.WS
23
DELISTED
Sable Offshore Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
SOC.WS
$18.1K 0.11%
57,836
ABTC
24
American Bitcoin Corp
ABTC
$418M
$16.1K 0.1%
+18
New +$20.1K
AVX
25
Avax One Technology Ltd
AVX
$25.8M
0

Similar funds

Ayrton Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Ayrton Capital held 93 positions worth $16M, down 42% from $27.9M the previous quarter. Its ten largest holdings account for 86% of the portfolio.

Ayrton Capital withdrew a net $21.9M in Q2 2023, closing 19 positions and reducing 3 holdings. Its most notable exit was Liberty Resources Acquisition Corp. Class A Common Stock, an estimated $1.84M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 17% a quarter earlier, followed by Financials and Real Estate.

Against the trend, Ayrton Capital opened a new position in Shuttle Pharmaceuticals worth $289K.

  • Ayrton Capital's largest Q2 2023 buy was Shuttle Pharmaceuticals: 125 shares worth $289K.
  • Ayrton Capital added most to PAVmed in Q2 2023, an estimated $8.6K increase.
  • Ayrton Capital's biggest Q2 2023 reduction was PharmaCyte Biotech, cutting an estimated $2.26M.
  • Ayrton Capital fully exited Liberty Resources Acquisition Corp. Class A Common Stock in Q2 2023, selling an estimated $1.84M.
  • Ayrton Capital's ten largest holdings make up 86% of its $16M portfolio in Q2 2023.
  • Ayrton Capital opened 6 new positions and closed 19 in Q2 2023.
  • Ayrton Capital's portfolio value fell 42% quarter-over-quarter to $16M.

Based on Ayrton Capital's 13F filing for Q2 2023, filed 14 Aug 2023.